Emerging concepts in outcome assessment for COPD clinical trials Source: Annual Congress 2007 - PG13 - Outcome measures of clinical trials for new drugs for respiratory disease Year: 2007
Missing data in IPF trials: do not let methodological issues undermine a major therapeutic breakthrough Source: Eur Respir J 2015; 46: 607-614 Year: 2015
Methodological issues in therapeutic trials of COPD Source: Eur Respir J 2008; 31: 927-933 Year: 2008
Revising our approach to conducting therapeutic clinical research in COPD Source: Eur Respir J, 51 (2) 1702712; 10.1183/13993003.02712-2017 Year: 2018
A systematic review of pharmacotherapeutic clinical trial end-points for bronchiectasis in adults Source: Eur Respir Rev, 28 (151) 180108; 10.1183/16000617.0108-2018 Year: 2019
Considerations of a real life pragmatic clinical trial in adolescent asthma Source: Eur Respir J, 58 (3) 2100461; 10.1183/13993003.00461-2021 Year: 2021
The pharmacoepidemiology of COPD: Recent advances and methodological discussion Source: Eur Respir J 2003; 22: 1S-44S Year: 2003
Challenges in COPD exacerbations and future research and unknowns Source: Annual Congress 2013 –Recommendations from the ERS/ATS Guideline on COPD Exacerbation Prevention Year: 2013
Methodological approaches to forecasting of cardiorespiratory disturbances in COPD Source: Eur Respir J 2006; 28: Suppl. 50, 39s Year: 2006
What is a COPD exacerbation? Current definitions, pitfalls, challenges and opportunities for improvement Source: Eur Respir J, 52 (5) 1801261; 10.1183/13993003.01261-2018 Year: 2018
A systematic evaluation of the diagnostic criteria for COPD and exacerbations used in randomised controlled trials on the management of COPD exacerbations Source: ERJ Open Res, 5 (4) 00136-2019; 10.1183/23120541.00136-2019 Year: 2019
COPD treatment from pathophysiology to clinical trials Source: ERS Live 2007 Year: 2007
Recommendations for epidemiological studies on COPD Source: Eur Respir J 2012; 39: 1277-1278 Year: 2012
Recommendations for epidemiological studies on COPD Source: Eur Respir J 2012; 39: 1278-1279 Year: 2012
Observational studies assessing the pharmacological treatment of obstructive lung disease: strengths, challenges and considerations for study design Source: ERJ Open Res, 6 (4) 00044-2020; 10.1183/23120541.00044-2020 Year: 2020
Current clinical trials Source: ERS Research Seminar 2017 – Immunotherapy: a new standard of care in thoracic malignancies? Year: 2017
Emerging challenges to the development and implementation of clinical practice guidelines – COPD as a case in point Source: Annual Congress 2008 - Guideline development workshop summary: ATS/ERS integrating and coordinating efforts in COPD Year: 2008